Sitravatinib-impurities | Pharmaffiliates

Sitravatinib

Sitravatinib (MGCD516) is an experimental drug for the treatment of cancer. It is a small molecule inhibitor of multiple tyrosine kinases. Reference standards of Sitravatinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Sitravatinib - API Standards 
    [catalogue_number] => PA 19 1710000
    [category_ids] => ,75,76,78,70,82,
    [chemical_name] => 
    [weight] => 629.68
    [form] => C33H29F2N5O4S
    [cas] => 1123837-84-2
    [pslug] => 1123837-84-2-sitravatinib-api-pa191710000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 19 1710000

Sitravatinib - API Standards


  • Catalogue No.:PA 19 1710000

  • CAS :

    1123837-84-2

  • Molecular Formula : C33H29F2N5O4S

  • Molecular Weight : 629.68